{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:48:15Z","timestamp":1755218895476,"version":"3.43.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction and importance:<\/jats:title>\n            <jats:p>Malignant melanoma has a generally poor prognosis and occurs primarily on the skin but may rarely be found in internal organs such as the small intestine, colon, or rectum.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation:<\/jats:title>\n            <jats:p>This report presents a case of a 78-year-old male patient with stage IV gastrointestinal melanoma, which is a rare form of melanoma. The patient received first-line pembrolizumab with a complete response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Clinical discussion:<\/jats:title>\n            <jats:p>Surgery plays a crucial role in local and regional control for patients with localized stages. Immune checkpoint inhibitor therapy, including nivolumab or pembrolizumab, is a well-studied and proven effective treatment option for patients with advanced skin melanoma. In this case report, the patient with gastrointestinal melanoma also had a very good response to immunotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Understanding gastrointestinal melanoma is still limited due to the rarity of this clinical entity. Currently, there are no standard treatment guidelines for this rare group of patients. Immune checkpoint inhibitors could be the preferred first-line therapy for patients with distant metastases.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000000902","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T08:18:00Z","timestamp":1691655480000},"page":"3140-3144","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Primary melanoma of the rectum: a case report of a rare tumor"],"prefix":"10.1097","volume":"85","author":[{"given":"Thang","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phuong Thanh","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2480-194X","authenticated-orcid":false,"given":"Hoa Thi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cuc Thi","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2023,6]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/BF02238576","article-title":"Changing epidemiology of anorectal melanoma","volume":"42","author":"Cagir","year":"1999","journal-title":"Dis Colon Rectum"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/1097-0142(196410)17:10<1323::AID-CNCR2820171015>3.0.CO;2-N","article-title":"Metastatic melanoma. A clinicopathological study","volume":"17","author":"Gupta","year":"1964","journal-title":"Cancer"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1093\/annonc\/mdx076","article-title":"Pembrolizumab KEYNOTE-001: an adaptive study leading to accelerated approval for two indications and a companion diagnostic","volume":"28","author":"Kang","year":"2017","journal-title":"Ann Oncol"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ijsu.2020.10.034","article-title":"The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines","volume":"84","author":"Agha","year":"2020","journal-title":"Int J Surg"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1002\/(SICI)1097-0142(19981015)83:8<1664::AID-CNCR23>3.0.CO;2-G","article-title":"The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade","volume":"83","author":"Chang","year":"1998","journal-title":"Cancer"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jaad.2006.06.017","article-title":"Primary mucosal melanoma","volume":"56","author":"Ronald","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1365-2559.1991.tb00831.x","article-title":"Melanocytes in the anal canal epithelium","volume":"18","author":"Clemmensen","year":"1991","journal-title":"Histopathology"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/bjs.6784","article-title":"Importance of clear resection margins in anorectal malignant melanoma","volume":"97","author":"Nilsson","year":"2010","journal-title":"Br J Surg"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S1470-2045(19)30274-8","article-title":"Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301\/KEYNOTE-252): a phase 3, randomised, double-blind study","volume":"20","author":"Long","year":"2019","journal-title":"Lancet Oncol"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12029-010-9216-2","article-title":"Management of anorectal melanoma: report of 17 cases and literature review","volume":"43","author":"Belbaraka","year":"2012","journal-title":"J Gastrointest Cancer"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s12032-014-0445-2","article-title":"Anorectal malignant melanoma: retrospective analysis of management and outcome in a single Portuguese Institution","volume":"32","author":"Miguel","year":"2015","journal-title":"Med Oncol"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/DCR.0000000000001872","article-title":"Anorectal mucosal melanoma in the era of immune checkpoint inhibition: should we change our surgical management paradigm?","volume":"64","author":"Adileh","year":"2021","journal-title":"Dis Colon Rectum"},{"key":"R14-20250806","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00432-022-03933-2","article-title":"Treatment outcomes and prognostic factors in 47 patients with primary anorectal malignant melanoma in the immune therapy era","volume":"149","author":"Ogata","year":"2023","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000902","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:28:27Z","timestamp":1754486907000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000000902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":14,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000000902","relation":{},"ISSN":["2049-0801"],"issn-type":[{"type":"electronic","value":"2049-0801"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"2023-03-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}